Patients hospitalized for COVID-19 who had COPD were more likely to die than those with asthma. Credit: Getty Images. Inpatients with COVID-19 with comorbid chronic obstructive pulmonary disease (COPD ...

Please provide your email address to receive an email when new articles are posted on . Twelve of 810 plasma metabolites were significantly associated with adrenal insufficiency. Patients with low ...

Flovent is a popular inhaled corticosteroid that helps keep inflammation in the lungs low and the airways open for people with asthma. Flovent is the brand name of fluticasone, a medication that has ...

Please provide your email address to receive an email when new articles are posted on . Based on data that showed improved ICS adherence with once-daily vs. twice-daily dosing among adults with asthma ...

Medically reviewed by Daniel More, MD Key Takeaways Asthma inhalers can be for quick relief or long-term control.Rescue inhalers work by relaxing your airway muscles to help you breathe better.People ...

Researchers found that a single daily preventive dose of inhaled corticosteroid is best taken at mid-afternoon for effective asthma control. Photo by coltsfan/Pixabay Folks with asthma might better ...

The market withdrawal of the brand-name asthma drug fluticasone propionate (Flovent) was linked to increased discontinuation of inhaled steroid therapy among children who had used the drug, a ...

Asthma is an umbrella diagnosis covering a number of heterogeneous inflammatory pathways. In the past, excessive T-helper cell type 2 (Th2) response and immunoglobulin E (IgE) sensitivity were thought ...

Inhaled cortical steroids (ICS) can help patients manage asthma symptoms, and recent updates to asthma treatment guidelines have expanded recommended, low-dose treatment. But concerns persist that ICS ...

Exacerbations of asthma are among the most common causes of hospitalization and outpatient visits, particularly among children and adolescents. Inhaled corticosteroid (ICS) therapy is the mainstay for ...

The FDA approved depemokimab (Exdensur) as the first ultra-long-acting biologic with twice-yearly dosing approved for ...

Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. On January 1, pharmaceutical company GlaxoSmithKline (GSK ...